良性前列腺增生症的免疫相关诊断标志物及其作为药物点的潜力
YaXuan Wang1,2, Jing Wang3, Jibin Liu1
1Cancer Research Centre Nantong, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, China.
Frontiers in immunology
|December 20, 2024
概括
使用机器学习识别了良性前列腺激增症 (BPH) 的新诊断标志物. 这些与免疫相关的标记物显示出作为BPH诊断和治疗的治疗点的希望.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 生物信息学是一种生物信息学.
- 免疫学 免疫学 免疫学
背景情况:
- 良性前列腺增生 (BPH) 是老年男性中普遍存在的疾病.
- 目前的BPH诊断缺乏明确的标记,依赖于成像和尿流速评估.
- 开发精确的诊断标记对于改善BPH管理至关重要.
研究的目的:
- 为了确定良性前列腺增生症 (BPH) 的新型诊断标志物.
- 探索这些标记物与免疫细胞的关联.
- 评估它们作为BPH治疗点的潜力.
主要方法:
- 使用的基因表达综合 (GEO) 数据集用于BPH.
- 应用微分表达式分析和机器学习技术.
- 使用ssGSEA进行免疫细胞评分和分子对接进行药物亲和力分析.
主要成果:
- 确定了185个差异表达的基因,涉及ECM和TGF-β通路.
- 通过机器学习,DACH1,CACNA1D,STARD13和RUNDC3B被确定为关键的诊断标记.
- 与免疫细胞的验证关联以及与tamsulosin和finasteride的强烈结合亲和力.
结论:
- 引入了针对BPH的新型免疫相关诊断标志物.
- 这些标记物显示出作为预测诊断工具和治疗点的潜力.
- 提供了针对性BPH治疗和改善患者结果的基础.
相关概念视频
Disorders of the Male Reproductive System
319
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
319
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
57
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57


